| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
TECH
Bio-Techne
|
Aug 12, 2026 | HOLD |
Buy
+15.5% avg upside
21 analysts
|
$73.00
1.06% Upside
|
+0.0% | · |
|
ILMN
Illumina
|
Aug 10, 2026 | BUY |
Buy
-8.8% avg upside
31 analysts
|
$230.00
19.34% Upside
|
+0.1% | · |
|
NTRA
Natera
|
Aug 06, 2026 | BUY |
Strong Buy
-2.2% avg upside
27 analysts
|
$350.00
12.63% Upside
|
+16.7% | · |
|
BIO
Bio-Rad Laboratories
|
Aug 06, 2026 | BUY |
Buy
-0.7% avg upside
9 analysts
|
$390.00
8.03% Upside
|
+3.5% | · |
|
WAT
Waters
|
Aug 04, 2026 | BUY |
Strong Buy
-5.0% avg upside
31 analysts
|
$475.00
14.95% Upside
|
+4.4% | · |
|
GH
Guardant Health
|
Jul 31, 2026 | BUY |
Strong Buy
+2.2% avg upside
31 analysts
|
$200.00
25.35% Upside
|
-2.8% | · |
|
AVTR
Avantor
|
Jul 29, 2026 | HOLD |
Buy
+11.7% avg upside
26 analysts
|
$14.00
1.16% Upside
|
-4.6% | · |
|
RGEN
Repligen
|
Jul 28, 2026 | BUY |
Strong Buy
+3.6% avg upside
25 analysts
|
$185.00
10.39% Upside
|
+14.3% | · |
|
TMO
Thermo Fisher
|
Jul 23, 2026 | HOLD |
Strong Buy
+1.3% avg upside
38 analysts
|
$580.00
2.70% Downside
|
+4.8% | · |
|
DHR
Danaher
|
Jul 21, 2026 | BUY |
Strong Buy
+3.2% avg upside
45 analysts
|
$215.00
5.47% Upside
|
+14.3% | · |
|
A
Agilent
|
May 26, 2026 | BUY |
Strong Buy
-0.0% avg upside
33 analysts
|
$153.00
2.52% Upside
|
+29.2% | · |
|
BRKR
Bruker
|
May 07, 2026 | HOLD |
Buy
-1.8% avg upside
22 analysts
|
$45.00
22.24% Downside
|
+32.2% | · |
|
CERT
Certara
|
Mar 09, 2026 | BUY |
Buy
+61.3% avg upside
22 analysts
|
$10.00
22.63% Upside
|
+14.1% | · |
|
CRL
Charles River Labs
|
Feb 25, 2026 | HOLD |
Strong Buy
-16.6% avg upside
35 analysts
|
$175.00
37.83% Downside
|
+66.0% | · |
|
TXG
10x Genomics
|
Feb 19, 2026 | HOLD |
Buy
-29.1% avg upside
18 analysts
|
$20.00
65.58% Downside
|
+195.2% | · |
|
WST
West Pharmaceutical Services
|
Feb 13, 2026 | BUY |
Strong Buy
+5.7% avg upside
18 analysts
|
$340.00
1.71% Downside
|
+38.4% | · |
|
QGEN
Qiagen
|
Feb 09, 2026 | HOLD |
Buy
-0.5% avg upside
24 analysts
|
$52.00
20.23% Upside
|
-16.0% | · |
|
IQV
IQVIA Holdings
|
Feb 06, 2026 | BUY |
Strong Buy
+1.5% avg upside
39 analysts
|
$240.00
0.64% Downside
|
+26.6% | · |
|
CYRX
CryoPort
|
Nov 05, 2025 | BUY |
Strong Buy
+8.0% avg upside
15 analysts
|
$12.50
17.44% Downside
|
+77.6% | · |
|
ICLR
Icon
|
Oct 24, 2025 | BUY |
Strong Buy
+12.5% avg upside
26 analysts
|
$220.00
31.37% Upside
|
-8.6% | · |
|
STVN
Stevanato Group
|
Aug 06, 2025 | HOLD |
Strong Buy
+28.0% avg upside
13 analysts
|
$28.00
30.20% Upside
|
-15.3% | · |
|
MEDP
Medpace Holdings
|
Jul 29, 2025 | SELL |
Buy
-16.9% avg upside
17 analysts
|
$305.00
47.65% Downside
|
-30.6% | · |
|
MTD
Mettler-Toledo
|
May 19, 2025 | BUY |
Buy
-15.2% avg upside
18 analysts
|
$1350.00
5.66% Downside
|
-9.3% | · |
|
RVTY
Revvity
|
May 01, 2025 | BUY |
Buy
-7.9% avg upside
23 analysts
|
$115.00
2.14% Downside
|
-6.4% | · |
|
FLGT
Fulgent Genetics
|
Mar 02, 2025 | HOLD |
Buy
+137.1% avg upside
7 analysts
|
$20.00
7.21% Upside
|
-7.1% | · |
|
MRVI
Maravai Lifesciences Holdings
|
Aug 08, 2024 | HOLD |
Strong Buy
+148.4% avg upside
17 analysts
|
$11.00
90.25% Upside
|
-74.1% | · |
|
GB:0AI4
Carlsberg AS
|
Apr 08, 2024 | HOLD |
Buy
+10.5% avg upside
20 analysts
|
$960.00
4.86% Upside
|
-11.0% | · |
|
ADPT
Adaptive Biotechnologies
|
Feb 14, 2023 | SELL |
Strong Buy
-3.5% avg upside
15 analysts
|
$7.00
71.45% Downside
|
+54.6% | · |
|
LH
Labcorp Holdings
|
Feb 11, 2022 | BUY |
Strong Buy
-15.9% avg upside
37 analysts
|
$320.00
0.85% Downside
|
-10.2% | · |
|
DGX
Quest Diagnostics
|
Feb 04, 2022 | HOLD |
Buy
-22.3% avg upside
34 analysts
|
$145.00
38.66% Downside
|
+8.6% | · |
|
RHP
Ryman
|
Oct 18, 2021 | BUY |
Strong Buy
-3.5% avg upside
18 analysts
|
$95.00
23.89% Downside
|
-0.6% | · |
|
BIORQ
Biora Therapeutics
|
Jul 14, 2020 | BUY |
Buy
+269249900.0% avg upside
6 analysts
|
$11.00
10999900.06% Upside
|
· | · |
|
MYGN
Myriad Genetics
|
Aug 14, 2019 | HOLD |
Hold
+462.3% avg upside
24 analysts
|
$35.00
1004.01% Upside
|
-50.3% | · |
|
BDX
Becton Dickinson
|
Dec 06, 2018 | BUY |
Buy
+7.8% avg upside
25 analysts
|
$280.00
53.86% Upside
|
+9.4% | · |
|
TTOO
T2 Biosystems
|
Jul 08, 2016 | BUY |
Buy
+1421150.0% avg upside
10 analysts
|
$7.00
1399899.96% Upside
|
· | · |
|
CDNA
CareDx
|
Jun 20, 2016 | BUY |
Buy
-14.4% avg upside
17 analysts
|
— | · | · |
|
VCYT
Veracyte
|
Jun 20, 2016 | BUY |
Strong Buy
+18.0% avg upside
19 analysts
|
— | +48.7% | · |
|
ABT
Abbott Laboratories
|
Jun 16, 2016 | HOLD |
Strong Buy
+4.4% avg upside
36 analysts
|
— | +31.8% | · |
|
HTGMQ
HTG Molecular Diagnostics
|
May 23, 2016 | BUY |
Strong Buy
+733333233.4% avg upside
6 analysts
|
$4.00
399999900.07% Upside
|
· | · |
|
CRDF
Cardiff Oncology
|
May 11, 2016 | HOLD |
Buy
+838.8% avg upside
18 analysts
|
$3.50
255.78% Upside
|
· | · |
|
LAB
Standard BioTools
|
Apr 12, 2016 | BUY |
Strong Buy
+705.5% avg upside
8 analysts
|
$15.00
1900.55% Upside
|
-43.7% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.